de Riese W, Goldenberg K, Allhoff E, Stief C, Schlick R, Liedke S, Jonas U
Department of Urology, Hannover Medical School (HMS), Germany.
Int Urol Nephrol. 1991;23(1):13-25. doi: 10.1007/BF02549723.
We report 4 cases of metastatic renal cell carcinoma (RCC) with long-term survival either following radical nephrectomy alone or in combination with radio- or hormonal therapy. Two patients with lymph node metastases showed a long-term survival of 12 or more years following radical tumour nephrectomy (with lymphadenectomy) and radiotherapy. One of them exhibited a histologically proven tumour recurrence nearly 12 years after primary surgical treatment and died shortly later; the other one is still without any evidence of metastatic disease. Two other patients exhibited spontaneous regression of pulmonary metastases: one regression occurred after radical tumour nephrectomy alone, the other one after successful primary hormonal treatment and subsequent radical tumour nephrectomy. The following important aspects are emphasized: 1. Renal cell carcinoma is a very unpredictable tumour. Once the diagnosis of renal cell carcinoma is proved, a patient can never be considered cured. 2. Although adjuvant palliative nephrectomy has produced contradictory results in several reports, radical tumour nephrectomy either alone or in combination with other adjuvant therapies such as radiotherapy, hormonal or immunological treatment, can be worthwhile. Cases with long-term survival and spontaneous regression of distant metastases are proof of this. Besides, if carefully selected, the mortality rate of different adjuvant therapies is not significantly higher in patients with metastatic disease than in patients without metastases. The world literature on this subject is reviewed.
我们报告了4例转移性肾细胞癌(RCC)患者,他们在单独接受根治性肾切除术或联合放疗或激素治疗后实现了长期生存。两名有淋巴结转移的患者在接受根治性肿瘤肾切除术(加淋巴结清扫术)和放疗后,长期生存达12年或更长时间。其中一名患者在初次手术治疗近12年后出现经组织学证实的肿瘤复发,随后不久死亡;另一名患者仍无任何转移性疾病的迹象。另外两名患者的肺转移灶出现自发消退:一例在单独接受根治性肿瘤肾切除术后消退,另一例在成功接受初始激素治疗及随后的根治性肿瘤肾切除术后消退。强调了以下重要方面:1.肾细胞癌是一种非常难以预测的肿瘤。一旦肾细胞癌的诊断得到证实,患者就绝不能被视为已治愈。2.尽管在几份报告中辅助性姑息性肾切除术产生了相互矛盾的结果,但单独进行根治性肿瘤肾切除术或与放疗、激素或免疫治疗等其他辅助治疗联合使用,可能是值得的。长期生存和远处转移灶自发消退的病例证明了这一点。此外,如果仔细挑选,转移性疾病患者接受不同辅助治疗的死亡率并不比无转移患者显著更高。本文对该主题的世界文献进行了综述。